Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Childhood Treatment with Adeno-Associated Viral Gene Therapy Results in Stable FVIII Expression and Improved Bleeding Phenotype in Adult Severe Hemophilia A Dogs

Paul Batty, Alex Menard, Aomei Mo, Christine Brown, Ashrafali M Ismail, Bridget Yates, Laura Swystun, Lori Harpell, Abbey Pender, Andrew Winterborn, Sylvia Fong, David Lillicrap

Blood (2023) 142 (Supplement 1): 2248.

https://doi.org/10.1182/blood-2023-174468

Published: 2023

Journal Articles

Omental implantation of BOECs in hemophilia dogs results in circulating FVIII antigen and a complex immune response

Margareth C. Ozelo, Barbara Vidal, Christine Brown, Colleen Notley, Carol Hegadorn, Sandra Webster, Lori Harpell, James Ahlin, Andrew Winterborn, Janine Handforth, Valder R. Arruda, Christine Hough, David Lillicrap

Blood (2014) 123 (26): 4045–4053.

https://doi.org/10.1182/blood-2013-12-545780

Published: 2014

Includes: Supplemental data

Journal Articles

Solulin increases clot stability in whole blood from humans and dogs with hemophilia

Jonathan H. Foley, Karl-Uwe Petersen, Catherine J. Rea, Lori Harpell, Sandra Powell, David Lillicrap, Michael E. Nesheim, Benny Sørensen

Blood (2012) 119 (15): 3622–3628.

https://doi.org/10.1182/blood-2011-11-392308

Published: 2012

Journal Articles

Immune-Modulatory Effects of Mesenchymal Stromal Cell Infusions for the Treatment of Factor VIII Inhibitor in Hemophilia A.

Hideto Matsui, MD, PhD, Lori Harpell, Sandra Powell, Moutih Rafei, PhD, Jacques Galipeau, MD, Christine Hough, PhD, David Lillicrap, MD

Blood (2009) 114 (22): 1299.

https://doi.org/10.1182/blood.V114.22.1299.1299

Published: 2009

Journal Articles

Genetically-Engineered Endothelial Cells Implanted Into the Omentum of Hemophilia A Dogs Provides Long-Term Circulating FVIII Resulting From Sustained FVIII Expression and Persistent Cell Viability.

Margareth C Ozelo, M.D., Ph.D., Hideto Matsui, MD, PhD, Carol A. Hegadorn, Lori Harpell, Sandra Powell, James F Hulvat, Ph.D., Andrew Winterborn, DVM, DACLAM, Janine Handforth, BSc, (Hons., Biol), DVM, Christine Hough, PhD, David Lillicrap, MD

Blood (2009) 114 (22): 3578.

https://doi.org/10.1182/blood.V114.22.3578.3578

Published: 2009

NARROW

Childhood Treatment with Adeno-Associated Viral Gene Therapy Results in Stable FVIII Expression and Improved Bleeding Phenotype in Adult Severe Hemophilia A Dogs

Omental implantation of BOECs in hemophilia dogs results in circulating FVIII antigen and a complex immune response

Solulin increases clot stability in whole blood from humans and dogs with hemophilia

Immune-Modulatory Effects of Mesenchymal Stromal Cell Infusions for the Treatment of Factor VIII Inhibitor in Hemophilia A.

Genetically-Engineered Endothelial Cells Implanted Into the Omentum of Hemophilia A Dogs Provides Long-Term Circulating FVIII Resulting From Sustained FVIII Expression and Persistent Cell Viability.

Email alerts

ASH Publications

American Society of Hematology

Childhood Treatment with Adeno-Associated Viral Gene Therapy Results in Stable FVIII Expression and Improved Bleeding Phenotype in Adult Severe Hemophilia A Dogs

Omental implantation of BOECs in hemophilia dogs results in circulating FVIII antigen and a complex immune response

Solulin increases clot stability in whole blood from humans and dogs with hemophilia

Immune-Modulatory Effects of Mesenchymal Stromal Cell Infusions for the Treatment of Factor VIII Inhibitor in Hemophilia A.

Genetically-Engineered Endothelial Cells Implanted Into the Omentum of Hemophilia A Dogs Provides Long-Term Circulating FVIII Resulting From Sustained FVIII Expression and Persistent Cell Viability.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only